Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
786 studies found for:    pharmacogenomics OR pharmacogenetics
Show Display Options
RSS Create an RSS feed from your search for:
pharmacogenomics OR pharmacogenetics
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy
Conditions: Stroke;   Transient Ischemic Attack;   Myocardial Infarction
Intervention: Other: Pharmacogenomics testing for clopidogrel responsiveness
2 Active, not recruiting Pharmacogenomics and Effective Treatment With Clopidogrel
Condition: Pharmacogenomics
Intervention: Genetic: Pharmacogenomics
3 Not yet recruiting A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program
Condition: Adverse Drug Reaction
Intervention: Device: Pharmacogenetic Intervention Arm (pharmacogenetic testing)
4 Completed
Has Results
Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin
Condition: Thromboembolism
Interventions: Genetic: IWPC adapted genotype-guided dosing algorithm for warfarin;   Genetic: Modified IWPC genetic-guided warfarin dosing algorithm;   Other: Standard of care treatment
5 Completed Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group
Conditions: Major Depressive Disorder;   Major Depression;   Unipolar Depression
Intervention: Drug: fluoxetine or desipramine
6 Recruiting Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Disease
Interventions: Other: Genotype-guided warfarin dosing;   Other: Non-genotype guided warfarin dosing
7 Completed
Has Results
Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm
Conditions: Atrial Fibrillation;   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention: Genetic: Warfarin Dose based on pharmacogenetics
8 Active, not recruiting Pharmacogenetic Testing in Primary Care
Condition: Pharmacogenetic Testing
Intervention:
9 Completed Renal Function and Pharmacogenetics in Renal Transplant Recipients Converted From Tac BID to Tac OD
Conditions: Real Function Post Conversion From Prograf to Advagraf;   Examin Ethnicity and Pharmacogenetics of the Cohort Requiring Dose Adjustment Post-conversion
Intervention:
10 Completed Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System Reinforced With Patient Specific Pharmacogenetic Data for Minimizing Severe Drug-Drug Interactions
Condition: Healthcare
Intervention: Other: DDI+ System and Pharmacogenetic Data
11 Recruiting Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Condition: Genetics of Drug Metabolism
Intervention:
12 Recruiting Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
Condition: Bipolar Affective Disorder
Intervention: Drug: Mood stabilizer treatment
13 Unknown  Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients
Condition: Renal Transplantation
Interventions: Other: drug (tacrolimus and SchE) and genetics;   Drug: tacrolimus
14 Unknown  Pharmacogenomics Studies of Antidepressants
Conditions: Major Depressive Disorder;   Antidepressive Agents;   Pharmacogenetics;   Venlafaxine;   Fluoxetine
Interventions: Drug: Venlafaxine;   Drug: Fluoxetine
15 Completed Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia
Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Intervention:
16 Completed Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)
Condition: HIV Infections
Intervention:
17 Completed Pharmacogenetics of Warfarin in Puerto Ricans.
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Antiphospholipid Syndrome;   Coagulopathy
Intervention:
18 Recruiting Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness
Conditions: Depression;   Antidepressant Drug Adverse Reaction
Interventions: Drug: SSRI class antidepressant;   Drug: non-SSRI class antidepressant
19 Unknown  Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention:
20 Withdrawn Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: Cisplatin;   Drug: Cetuximab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years